United States Body Firming Creams Market Size & Outlook, 2025-2033
United States Body Firming Creams Market Insights
- Deep Market Insights analysis indicates that the United States Body Firming Creams Market size, valued at USD 879.95 Million in 2024, is expected to expand to USD 1536.74 Million by 2033.
- The United States market is forecasted to expand at a CAGR of 6.42% spanning 2026–2033.
- Caffeine-Based held the leading position among Ingredient Type segments in 2024, based on market size.
- Retinol-Based is projected to post the fastest growth rate, sustaining its position as the most attractive Ingredient Type segment during the forecast horizon.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- United States contributed 23.97% to the global Body Firming Creams Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Body Firming Creams Market.
- In North America, United States is projected to capture the leading share of market size by 2033.
- Among North America markets, Canada is expected to post the fastest growth, reaching USD 524.53 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 879.95 Million |
| Market Size In 2033 | USD 1536.74 Million |
| Largest segment | Caffeine-Based |
| Units | Revenue in USD Million |
| CAGR | 6.42% (2025-2033) |
| Segmnetation Covered | |
| Ingredient Type |
|
| Application Area |
|
| Consumer Type |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
United States Body Firming Creams Market Ingredient Type 2025-2033 (USD Million)
| Ingredient Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caffeine-Based | XX.x | XX.x | XX.x | 405.57 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Retinol-Based | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Herbal Extracts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Peptide-Based | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Body Firming Creams Market Application Area 2025-2033 (USD Million)
| Application Area | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abdomen | XX.x | XX.x | XX.x | 352.42 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Thighs | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Arms | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Bust | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.
United States Body Firming Creams Market Consumer Type 2025-2033 (USD Million)
| Consumer Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Women | XX.x | XX.x | XX.x | 402.14 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Men | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Post-Pregnancy Users | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Fitness Enthusiasts | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.